[Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
The value of the assay of the sub-units of human chorionic gonadotrophin in the diagnosis and follow-up of trophoblastic disease is generally recognised. The authors stress that this follow-up allows a maximal preservation of the genital tract of the patients and an evaluation of the real effectiveness of treatment.
P J
PJ
Delpont
H
H
Ruf
B
B
Blanc
M
M
Gamerre
J
J
Adrai
M
M
Conte
S
S
Dupont
J
J
Bellia-Rousseau
D000328:Adult; D002822:Choriocarcinoma / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D015292:Glycoprotein Hormones, alpha Subunit; D006801:Humans; D006828:Hydatidiform Mole / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D011247:Pregnancy; D011379:Prognosis; D011863:Radioimmunoassay; D014328:Trophoblastic Neoplasms / Q000097:blood* / Q000628:therapy; D014594:Uterine Neoplasms / Q000097:blood* / Q000628:therapy
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D015292:Glycoprotein Hormones, alpha Subunit; D010446:Peptide Fragments
Intérêt du dosage radio-immunologique d'hCG et sous-unités dans le diagnostic et la surveillance des maladies trophoblastiques gestationnelles.